Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
600079.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
-28%
0.13
vs 0.18
Q1.23
-27%
0.41
vs 0.56
Q2.23
-5%
0.4
vs 0.42
Q3.23
-35%
0.27
vs 0.42
Q4.23
+69%
0.22
vs 0.13
Q1.24
-27%
0.3
vs 0.41
Q2.24
-4%
0.38
vs 0.4
Q3.24
+8%
0.29
vs 0.27
Q4.24
N/A
-0.16
vs 0.22
Q1.25
+11%
0.33
vs 0.3
Sales Growth
YoY
Current
Estimates
Q4.22
+7%
6.1B vs 5.7B
Q1.23
+20%
6.2B vs 5.2B
Q2.23
+14%
6.2B vs 5.4B
Q3.23
+1%
5.7B vs 5.7B
Q4.23
+4%
6.3B vs 6.1B
Q1.24
+1%
6.3B vs 6.2B
Q2.24
+5%
6.4B vs 6.2B
Q3.24
+10%
6.3B vs 5.7B
Q4.24
-1%
6.3B vs 6.3B
Q1.25
-3%
6.1B vs 6.3B
Return on Equity
QoQ
Q2.23
+4%
0.04
vs 0.04
Q3.23
+3%
0.03
vs 0.04
Q4.23
+2%
0.02
vs 0.03
Q1.24
+3%
0.03
vs 0.02
Q2.24
+4%
0.04
vs 0.03
Q3.24
+3%
0.03
vs 0.04
Q4.24
-1%
-0.01
vs 0.03
Q1.25
+3%
0.03
vs -0.01
Institutionnal Ownership
Quote Panel
Key Metrics
Forecast
372%2026-Revenue
394%2026-EPS
477%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
600079.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Humanwell Healthcare (Group) Co.,Ltd. provides healthcare solutions in the Asia Pacific, North America, Africa, and internationally. The company offers anesthetic/analgesic products; women's health products for unplanned pregnancy, emergency contraception, and birth control; consumer healthcare products for women; and CNS drugs for bronchitis, migraine, dysmenorrhea, neuralgia, epilepsy, acute and chronic cerebrovascular diseases, and brain injury and peripheral vascular diseases. It also provides herbal medicines for cold and flu, rheumatoid arthritis, skin care, hepatitis, urinary tract infection, and hypomnesis; anti-infection drugs; OTC medicines for digestive disorders, cold and flu, anti-inflammation, anti-infection, and nutritional supplements; and other products targeting cardiovascular, gastrointestinal, and reproductive diseases. The company was formerly known as Wuhan Humanwell Healthcare (Group) Co., Ltd. and changed its name to Humanwell Healthcare (Group) Co.,Ltd. in March 2013. Humanwell Healthcare (Group) Co.,Ltd. was founded in 1993 and is based in Wuhan, China.
SHH
EPS improving
EPS improving
0.06Â ( 0.28%)
Relative Strenght
Volume Buzz
31%
Earning Acce
No
Dist 52w H.
18%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 600079.SS compares to sector?